Nonadherence to antiseizure medications: what have we learned and what can be done next?

References

• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi: 10.1111/j.1365-2125.2012.04167.x
   PubMed Web of Science ®Google Scholar
• Lehane E, McCarthy G. Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud Elsevier Ltd. 2007;44(8):1468–1477. doi: 10.1016/j.ijnurstu.2006.07.010
   PubMed Web of Science ®Google Scholar
• Al-Hassany L, Kloosterboer SM, Dierckx B, et al. Assessing methods of measuring medication adherence in chronically ill children–a narrative review. Patient prefer adherence. Dove Medical Press Ltd.; 2019. p. 1175–1189. doi: 10.2147/PPA.S200058
   Google Scholar
• Tonin FS, Wiecek E, Torres-Robles A, et al. An innovative and comprehensive technique to evaluate different measures of medication adherence: the network meta-analysis. Res Social Administrative Pharm. 2019;15(4):358–365. doi: 10.1016/j.sapharm.2018.05.010
   PubMed Web of Science ®Google Scholar
• Konstantinou P, Kasinopoulos O, Karashiali C, et al. A scoping review of methods used to assess medication adherence in patients with chronic conditions. Annals of behavioral medicine. Oxford University Press; 2022. p. 1201–1217. doi: 10.1093/abm/kaab080
   Google Scholar
• Monnette A, Zhang Y, Shao H, et al. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices: an updated review. Pharmacoeconomics Springer International Publishing. 2018; 36. 17–27.
   PubMed Web of Science ®Google Scholar
• Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–482. doi: 10.1111/epi.12550
   PubMed Web of Science ®Google Scholar
• Beghi E, Giussani G, Abd-Allah F, et al. Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the global burden of disease study 2016. The Lancet Neurology. 2019;18(4):357–375. doi: 10.1016/S1474-4422(18)30454-X
   PubMed Web of Science ®Google Scholar
• Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2197–2223. doi: 10.1016/S0140-6736(12)61689-4
   PubMed Web of Science ®Google Scholar
• Begley C, Wagner RG, Abraham A, et al. The global cost of epilepsy: a systematic review and extrapolation. Epilepsia. 2022;63(4):892–903. doi: 10.1111/epi.17165
   PubMed Web of Science ®Google Scholar
• Allers K, Essue BM, Hackett ML, et al. The economic impact of epilepsy: a systematic review. BMC Neurol. 2015;15(1):15. doi: 10.1186/s12883-015-0494-y
   PubMedGoogle Scholar
• Epilepsy a public health imperative.
   Google Scholar
• Malek N, Heath CA, Greene J. A review of medication adherence in people with epilepsy. Acta Neurol Scand. Blackwell Publishing Ltd; 2017. p. 507–515. doi: 10.1111/ane.12703
   Google Scholar
• Konstantinou P, Kassianos AP, Georgiou G, et al. Barriers, facilitators, and interventions for medication adherence across chronic conditions with the highest non-adherence rates: a scoping review with recommendations for intervention development. Transl Behav Med. Oxford University Press; 2020. p. 1390–1398. doi: 10.1093/tbm/ibaa118
   Google Scholar
• Yang C, Hao Z, Yu D, et al. The prevalence rates of medication adherence and factors influencing adherence to antiepileptic drugs in children with epilepsy: a systematic review and meta analysis. Epilepsy Res. 2018;142:88–99. doi: 10.1016/j.eplepsyres.2018.03.018
   PubMed Web of Science ®Google Scholar
• Cutler RL, Fernandez-Llimos F, Frommer M, et al. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. BMJ Publishing Group; 2018. doi: 10.1136/bmjopen-2017-016982
   Google Scholar
• Davis KL, Candrilli SD, Edin HM. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Epilepsia. 2008;49(3):446–454. doi: 10.1111/j.1528-1167.2007.01414.x
   PubMed Web of Science ®Google Scholar
• Faught E, Duh MS, Weiner JR, et al. Nonadherence to antiepileptic drugs and increased mortality. Neurology. 2008;71(20):1572–1578. doi: 10.1212/01.wnl.0000319693.10338.b9
   PubMed Web of Science ®Google Scholar
• Faught RE, Weiner JR, Guérin A, et al. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia. 2009;50(3):501–509. doi: 10.1111/j.1528-1167.2008.01794.x
   PubMed Web of Science ®Google Scholar
• Mendorf S, Prell T, Schönenberg A. Detecting reasons for nonadherence to medication in adults with epilepsy: a review of self-report measures and key predictors. J Clin Med MDPI. 2022;11(15):4308. doi: 10.3390/jcm11154308
   PubMed Web of Science ®Google Scholar
• Rourke G O’, Brien JJ O’. Identifying the barriers to antiepileptic drug adherence among adults with epilepsy. Seizure. W.B. Saunders Ltd; 2017. p. 160–168. doi: 10.1016/j.seizure.2016.12.006
   Google Scholar
• Bakula DM, Junger KW, Guilfoyle SM, et al. Key predictors of the need for a family-focused pediatric epilepsy adherence intervention. Epilepsia. 2022;63(8):2120–2129. doi: 10.1111/epi.17302
   PubMed Web of Science ®Google Scholar
• Huber R, Weber P. Is there a relationship between socioeconomic factors and prevalence, adherence and outcome in childhood epilepsy? A systematic scoping review. Eur J Paediatr Neurol. W.B. Saunders Ltd. 2022;38:1–6. doi: 10.1016/j.ejpn.2022.01.021
   PubMed Web of Science ®Google Scholar
• Horne R, Chapman SCE, Parham R, et al. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLOS ONE. 2013;8(12):e80633. doi: 10.1371/journal.pone.0080633
   PubMed Web of Science ®Google Scholar
• Foley L, Larkin J, Lombard-Vance R, et al. Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open. BMJ Publishing Group; 2021. doi: 10.1136/bmjopen-2020-044987
   Google Scholar
• Gast A, Mathes T. Medication adherence influencing factors—an (updated) overview of systematic reviews. Syst Rev BioMed Central Ltd. 2019;8(1). doi: 10.1186/s13643-019-1014-8
   Google Scholar
• Kardas P, Aarnio E, Agh T, et al. New terminology of medication adherence enabling and supporting activities: ENABLE terminology. Front Pharmacol. 2023;14:14. doi: 10.3389/fphar.2023.1254291
   Web of Science ®Google Scholar
• Wilhelmsen NC, Eriksson T. Medication adherence interventions and outcomes: an overview of systematic reviews. Eur J Hosp Pharm. BMJ Publishing Group 2019;26(4):187–192. doi: 10.1136/ejhpharm-2018-001725
   PubMedGoogle Scholar
• Anderson LJ, Nuckols TK, Coles C, et al. A systematic overview of systematic reviews evaluating medication adherence interventions. Am J Health Syst Pharm. 2020;77(2):138–147. doi: 10.1093/ajhp/zxz284
   PubMed Web of Science ®Google Scholar
• Kini V, Michael Ho P. Interventions to improve medication adherence: a review. JAMA - J Am Med Assoc. 2018;320(23):2461–2473. doi: 10.1001/jama.2018.19271
   PubMed Web of Science ®Google Scholar
• Torres-Robles A, Wiecek E, Tonin FS, et al. Comparison of interventions to improve long-term medication adherence across different clinical conditions: a systematic review with network meta-analysis. Front Pharmacol. 2018;9. doi: 10.3389/fphar.2018.01454
   PubMed Web of Science ®Google Scholar
• Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis. Prev med (Baltim). Academic Press Inc.; 2017. p. 269–276. doi: 10.1016/j.ypmed.2017.03.008
   Google Scholar
• Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane database of systematic reviews. John Wiley and Sons Ltd; 2014. doi: 10.1002/14651858.CD000011.pub4
   Google Scholar
• Al-Aqeel S, Gershuni O, Al-Sabhan J, et al. Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy. Cochrane Database Syst Rev. 2020;2020(10). doi: 10.1002/14651858.CD008312.pub4
   Google Scholar
• da Mota Gomes M, Navarro T, Keepanasseril A, et al. Increasing adherence to treatment in epilepsy: what do the strongest trials show? Acta Neurol Scand. Blackwell Publishing Ltd; 2017. p. 266–272. doi: 10.1111/ane.12668
   Google Scholar
• Godara K, Phakey N, Garg D, et al. Interventions to improve medication adherence in children with epilepsy: a systematic review. Cureus [Internet]. 2024. doi: 10.7759/cureus.54680
   Web of Science ®Google Scholar
• Dash D, Sebastian TM, Aggarwal M, et al. Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy Behav. 2015;44:213–217. doi: 10.1016/j.yebeh.2014.12.030
   PubMed Web of Science ®Google Scholar
• DiIorio C, Bamps Y, Walker ER, et al. Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy Behav. 2011;22(3):469–474. doi: 10.1016/j.yebeh.2011.07.030
   PubMed Web of Science ®Google Scholar
• Edward K, Cook M, Stephenson J, et al. The impact of brief lifestyle self-management education for the control of seizures. Br J Nurs. 2019;28(6):348–354. doi: 10.12968/bjon.2019.28.6.348
   PubMedGoogle Scholar
• Ibinda F, Mbuba CK, Kariuki SM, et al. Evaluation of kilifi epilepsy education programme: a randomized controlled trial. Epilepsia. 2014;55(2):344–352. doi: 10.1111/epi.12498
   PubMed Web of Science ®Google Scholar
• Leenen LAM, Wijnen BFM, Kessels AGH, et al. Effectiveness of a multicomponent self-management intervention for adults with epilepsy (ZMILE study): a randomized controlled trial. Epilepsy Behav. 2018;80:259–265. doi: 10.1016/j.yebeh.2018.01.019
   PubMed Web of Science ®Google Scholar
• Li J, Si Y, Hu J, et al. Enhancing medical compliance of patients with convulsive epilepsy in rural community: a randomized intervention trial. Epilepsia. 2013;54(11):1988–1996. doi: 10.1111/epi.12382
   PubMed Web of Science ®Google Scholar
• Lua PL, Neni WS. A randomised controlled trial of an sms-based mobile epilepsy education system. J Telemed Telecare. 2013;19(1):23–28. doi: 10.1177/1357633X12473920
   PubMed Web of Science ®Google Scholar
• Mirpuri P, Chandra PP, Samala R, et al. The development and efficacy of a mobile phone application to improve medication adherence for persons with epilepsy in limited resource settings: a preliminary study. Epilepsy Behav. 2021;116:116. doi: 10.1016/j.yebeh.2021.107794
   Web of Science ®Google Scholar
• Modi AC, Guilfoyle SM, Rausch J. Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy. J Pediatr Psychol. 2013;38(6):605–616. doi: 10.1093/jpepsy/jst021
   PubMed Web of Science ®Google Scholar
• Modi AC, Mann KA, Urso L, et al. Preliminary feasibility and efficacy of text messaging and application-based adherence interventions in adolescents with epilepsy. Epilepsy Behav. 2016;63:46–49. doi: 10.1016/j.yebeh.2016.07.036
   PubMed Web of Science ®Google Scholar
• Modi AC, Guilfoyle SM, Mann KA, et al. A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy. Epilepsia. 2016;57(3):e69–e75. doi: 10.1111/epi.13289
   PubMed Web of Science ®Google Scholar
• Modi AC, Guilfoyle SM, Glauser TA, et al. Supporting treatment adherence regimens in children with epilepsy: a randomized clinical trial. Epilepsia. 2021;62(7):1643–1655. doi: 10.1111/epi.16921
   PubMed Web of Science ®Google Scholar
• Modi AC, Patel AD, Mara CA, et al. Pilot randomized controlled clinical trial of an adherence social norms intervention for adolescents with epilepsy. Epilepsy Behav. 2023;140:140. doi: 10.1016/j.yebeh.2022.109082
   Web of Science ®Google Scholar
• Pakpour AH, Gholami M, Esmaeili R, et al. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence. Epilepsy Behav. 2015;52:133–142. doi: 10.1016/j.yebeh.2015.08.036
   PubMed Web of Science ®Google Scholar
• Ridsdale L, Wojewodka G, Robinson EJ, et al. The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): a randomized controlled trial. Epilepsia. 2018;59(5):1048–1061. doi: 10.1111/epi.14073
   PubMed Web of Science ®Google Scholar
• Saengow VE, Chancharoenchai P, Saartying W, et al. Epilepsy video animation: impact on knowledge and drug adherence in pediatric epilepsy patients and caregivers. Clin Neurol Neurosur. 2018;172:59–61. doi: 10.1016/j.clineuro.2018.06.031
   PubMed Web of Science ®Google Scholar
• Tang F, Zhu G, Jiao Z, et al. The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy Behav. 2014;37:157–164. doi: 10.1016/j.yebeh.2014.05.017
   PubMed Web of Science ®Google Scholar
• Zheng Y, Ding X, Guo Y, et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy Behav. 2019;100:100. doi: 10.1016/j.yebeh.2019.07.001
   Web of Science ®Google Scholar
• Kardas P, Bago M, Barnestein-Fonseca P, et al. Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges. Front Pharmacol. 2022;13. doi: 10.3389/fphar.2022.944829
   Web of Science ®Google Scholar
• Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: the template for intervention description and replication (TIDieR) checklist and guide associate Professor of clinical epidemiology Professor of statistics in medicine CORE view metadata, citation and similar papers at core. Ac.uk provided by UCL discovery.
   Google Scholar
• Duncan E, O’Cathain A, Rousseau N, et al. Guidance for reporting intervention development studies in health research (GUIDED): an evidence-based consensus study. BMJ Open. 2020;10(4):10. doi: 10.1136/bmjopen-2019-033516
   Web of Science ®Google Scholar
• De Geest S, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP medication adherence reporting guideline (EMERGE). Ann Intern Med. 2018;169(1):30–35. doi: 10.7326/M18-0543
   PubMed Web of Science ®Google Scholar
• Carey RN, Connell LE, Johnston M, et al. Behavior change techniques and their mechanisms of action: a synthesis of links described in published intervention literature. Ann Behav Med. 2018;53:693–707. doi: 10.1093/abm/kay078
   Web of Science ®Google Scholar
• Conn VS, Enriquez M, Ruppar TM, et al. Meta-analyses of theory use in medication adherence intervention research. Am J Health Behav. 2016;40(2):155–171. doi: 10.5993/AJHB.40.2.1
   PubMed Web of Science ®Google Scholar
• Candy B, Vickerstaff V, Jones L, et al. Description of complex interventions: analysis of changes in reporting in randomised trials since 2002. Trials. 2018;19(1): doi: 10.1186/s13063-018-2503-0
   PubMedGoogle Scholar
• Dijkers MP. Overview of reviews using the template for intervention description and replication (TIDieR) as a measure of trial intervention reporting quality. Arch Phys Med Rehabil. W.B. Saunders 2021;102(8):1623–1632. doi: 10.1016/j.apmr.2020.09.397
   PubMed Web of Science ®Google Scholar
• Allemann SS, Nieuwlaat R, Navarro T, et al. Congruence between patient characteristics and interventions may partly explain medication adherence intervention effectiveness: an analysis of 190 randomized controlled trials from a cochrane systematic review. J Clin Epidemiol. Elsevier USA 2017;91:70–79.
   PubMed Web of Science ®Google Scholar
• Cheen MHH, Tan YZ, Oh LF, et al. Prevalence of and factors associated with primary medication non-adherence in chronic disease: a systematic review and meta-analysis. Int J Clin Pract. Blackwell Publishing Ltd. 2019;73(6):e13350. doi: 10.1111/ijcp.13350
   PubMed Web of Science ®Google Scholar
• Zeber JE, Manias E, Williams AF, et al. A systematic literature review of psychosocial and behavioral factors associated with initial medication adherence: a report of the ISPOR medication adherence & persistence special interest group. Value Health. 2013;16(5):891–900. doi: 10.1016/j.jval.2013.04.014
   PubMed Web of Science ®Google Scholar
• Sinnappah KA, Hughes DA, Stocker SL, et al. A framework for understanding sources of bias in medication adherence research. Br J Clin Pharmacol. 2023;89(11):3444–3453. doi: 10.1111/bcp.15863
   PubMed Web of Science ®Google Scholar
• Pednekar PP, Ágh T, Malmenäs M, et al. Methods for measuring multiple medication adherence: a systematic review–report of the ISPOR medication adherence and persistence special interest group. Value In Health. Elsevier Ltd. 2019;22(2):139–156. doi: 10.1016/j.jval.2018.08.006
   PubMed Web of Science ®Google Scholar
• Terman SW, Aubert CE, Hill CE, et al. Polypharmacy in patients with epilepsy: a nationally representative cross-sectional study. Epilepsy Behav. 2020;111:111. doi: 10.1016/j.yebeh.2020.107261
   Web of Science ®Google Scholar
• Conn VS, Ruppar TM, Enriquez M, et al. Patient-centered outcomes of medication adherence interventions: systematic review and meta-analysis. Value In Health. Elsevier Ltd. 2016;19(2):277–285. doi: 10.1016/j.jval.2015.12.001
   PubMed Web of Science ®Google Scholar
• Wijnen BFM, Leenen LAM, de Kinderen RJA, et al. An economic evaluation of a multicomponent self-management intervention for adults with epilepsy (ZMILE study). Epilepsia. 2017;58(8):1398–1408. doi: 10.1111/epi.13806
   PubMed Web of Science ®Google Scholar
• Ridsdale L, McKinlay A, Wojewodka G, et al. Self-management education for adults with poorly controlled epilEpsy [SMILE (UK)]: a randomised controlled trial. Health Technol Assess (Rockv). 2018;22(21):1–142. doi: 10.3310/hta22210
   Web of Science ®Google Scholar
• Plumpton CO, Brown I, Reuber M, et al. Economic evaluation of a behavior-modifying intervention to enhance antiepileptic drug adherence. Epilepsy Behav. 2015;45:180–186. doi: 10.1016/j.yebeh.2015.01.035
   PubMed Web of Science ®Google Scholar
• Wagner RG, Norström F, Bertram MY, et al. Community health workers to improve adherence to anti-seizure medication in rural South Africa: is it cost-effective? Epilepsia. 2021;62(1):98–106. doi: 10.1111/epi.16756
   PubMed Web of Science ®Google Scholar
• Al-Aqeel S, Alsugair J, Alghamdi R. Economic evaluation of interventions to improve medication adherence among patients with chronic diseases: an overview of systematic reviews. Expert Rev Pharmacoecon Outcomes Res. 2023;23(2):153–179. doi: 10.1080/14737167.2023.2161516
   PubMed Web of Science ®Google Scholar
• Ágh T, Hiligsmann M, Borah B, et al. Systematic review of outcomes for assessment of medication adherence enhancing interventions: an ISPOR special interest group report. Value In Health. Internet 2024;27(2):133–142. doi: 10.1016/j.jval.2
   PubMedGoogle Scholar
• Ágh T, Hadžiabdić MO, Garuoliene K, et al. Reimbursed medication adherence enhancing interventions in European Countries: results of the EUREcA study. Front Pharmacol. 2022;13. doi: 10.3389/fphar.2022.892240
   Web of Science ®Google Scholar
• Baumgartner PC, Haynes RB, Hersberger KE, et al. A systematic review of medication adherence thresholds dependent of clinical outcomes. Front Pharmacol. 2018;9. doi: 10.3389/fphar.2018.01290
   PubMed Web of Science ®Google Scholar
• O’Cathain A, Croot L, Duncan E, et al. Guidance on how to develop complex interventions to improve health and healthcare. BMJ Open. 2019;9(8):9. doi: 10.1136/bmjopen-2019-029954
   Web of Science ®Google Scholar
• O’Cathain A, Croot L, Sworn K, et al. Taxonomy of approaches to developing interventions to improve health: a systematic methods overview. Pilot Feasibility Stud. BioMed Central Ltd.; 2019. doi: 10.1136/bmjopen-2019-029954
   Google Scholar
• Khan MU, Brien JA, Aslani P. The use of discrete choice experiments in adherence research: a new solution to an old problem. Res Social Administrative Pharm Elsevier Inc. 2020;16(10):1487–1492. doi: 10.1016/j.sapharm.2020.02.013
   PubMed Web of Science ®Google Scholar
• Unni E, Bae S. Exploring a new theoretical model to explain the behavior of medication adherence. Pharmacy. 2022;10(2):43. doi: 10.3390/pharmacy10020043
   Web of Science ®Google Scholar
• Dima AL, Allemann SS, Dunbar-Jacob J, et al. TEOS: a framework for constructing operational definitions of medication adherence based on timelines–events–objectives–sources. Br J Clin Pharmacol. 2021;87(6):2521–2533. doi: 10.1111/bcp.14659
   PubMed Web of Science ®Google Scholar
• Möhler R, Köpke S, Meyer G. Criteria for reporting the development and evaluation of complex interventions in healthcare: revised guideline (CReDECI 2). Trials. 2015;16(1). doi: 10.1186/s13063-015-0709-y
   PubMedGoogle Scholar